Cargando…
Co-targeting of Tiam1/Rac1 and Notch ameliorates chemoresistance against doxorubicin in a biomimetic 3D lymphoma model
Lymphoma is a heterogeneous disease with a highly variable clinical course and prognosis. Improving the prognosis for patients with relapsed and treatment-resistant lymphoma remains challenging. Current in vitro drug testing models based on 2D cell culture lack natural tissue-like structural organiz...
Autores principales: | Ikram, Muhammad, Lim, Yeseon, Baek, Sun-Yong, Jin, Songwan, Jeong, Young Hun, Kwak, Jong-Young, Yoon, Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788621/ https://www.ncbi.nlm.nih.gov/pubmed/29416753 http://dx.doi.org/10.18632/oncotarget.23156 |
Ejemplares similares
-
Fish Scale Collagen Peptides Protect against CoCl(2)/TNF-α-Induced Cytotoxicity and Inflammation via Inhibition of ROS, MAPK, and NF-κB Pathways in HaCaT Cells
por: Subhan, Fazli, et al.
Publicado: (2017) -
TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer
por: Izumi, Daisuke, et al.
Publicado: (2019) -
The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation, and cell migration
por: Saxena, Madhurima, et al.
Publicado: (2013) -
Tiam1/Rac1 complex controls Il17a transcription and autoimmunity
por: Kurdi, Ahmed T., et al.
Publicado: (2016) -
The RAC1 activator Tiam1 regulates centriole duplication through controlling PLK4 levels
por: Porter, Andrew P., et al.
Publicado: (2021)